01 / Vendor Profile
GENSCRIPT USA INC Federal Contracts and Awards
UEI KVLBRRAQ6UX1 · CAGE 5THB5
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $18.65M in net contract obligations to GENSCRIPT USA INC across 363 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
GENSCRIPT USA INC contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$1.56M
FY 2025ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2019 | $3.14M | 56 | 4 | — |
| FY 2020 | $1.75M | 54 | 5 | −44.2% |
| FY 2021 | $4.18M | 53 | 8 | +138.4% |
| FY 2022 | $3.21M | 76 | 6 | −23.3% |
| FY 2023 | $3.06M | 62 | 6 | −4.8% |
| FY 2024 | $1.75M | 44 | 6 | −42.9% |
| FY 2025 | $1.56M | 18 | 3 | −10.8% |
04 / Federal Customers
Which federal agencies buy from GENSCRIPT USA INC?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $15.44M | 269 | 82.8% | |
| 7523 | $1.75M | 32 | 9.4% | |
| 12K3 | $881.7K | 8 | 4.7% | |
| 7524 | $217.6K | 18 | 1.2% | |
| 12H2 | $216.1K | 22 | 1.2% | |
| 1700 | $84.9K | 6 | 0.5% | |
| 7505 | $19.7K | 2 | 0.1% | |
| 3600 | $17.5K | 4 | 0.1% | |
| 6800 | $16.1K | 2 | 0.1% |
05 / Contracting Offices
Which contracting offices buy from GENSCRIPT USA INC?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N930 | NATIONAL INSTITUTES OF HEALTH | $8.96M | 160 | 48.1% | |
| 75N910 | NATIONAL INSTITUTES OF HEALTH | $5.75M | 42 | 30.9% | |
| 75D301 | CENTERS FOR DISEASE CONTROL AND PREVENTION | $1.75M | 32 | 9.4% | |
| 126395 | ANIMAL AND PLANT HEALTH INSPECTION SERVICE | $854.3K | 7 | 4.6% | |
| 75N940 | NATIONAL INSTITUTES OF HEALTH | $284.8K | 34 | 1.5% | |
| 75F401 | FOOD AND DRUG ADMINISTRATION | $217.6K | 18 | 1.2% | |
| 12805B | AGRICULTURAL RESEARCH SERVICE | $91.7K | 2 | 0.5% | |
| 75N950 | NATIONAL INSTITUTES OF HEALTH | $81.4K | 7 | 0.4% | |
| 75N920 | NATIONAL INSTITUTES OF HEALTH | $73.1K | 4 | 0.4% | |
| 12405B | AGRICULTURAL RESEARCH SERVICE | $71.6K | 11 | 0.4% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 621511 | MEDICAL LABORATORIES | $5.14M | 9 | 2 | 27.6% |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $4.64M | 71 | 3 | 24.9% |
| 325413 | IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING | $2.57M | 30 | 3 | 13.8% |
| 541380 | TESTING LABORATORIES AND SERVICES | $2.44M | 72 | 2 | 13.1% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $1.85M | 86 | 9 | 9.9% |
| 541990 | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES | $1.06M | 26 | 1 | 5.7% |
| 423490 | OTHER PROFESSIONAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS | $361.8K | 12 | 2 | 1.9% |
| 423450 | MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS | $249.8K | 1 | 1 | 1.3% |
| 334516 | ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING | $162.3K | 11 | 4 | 0.9% |
| 621991 | BLOOD AND ORGAN BANKS | $148.1K | 20 | 1 | 0.8% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| Q301 | MEDICAL- LABORATORY TESTING | $8.70M | 138 | 4 | 46.7% |
| 6505 | DRUGS AND BIOLOGICALS | $6.31M | 98 | 1 | 33.8% |
| 6640 | LABORATORY EQUIPMENT AND SUPPLIES | $1.48M | 35 | 6 | 7.9% |
| 6550 | IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1.39M | 26 | 5 | 7.5% |
| 6509 | DRUGS AND BIOLOGICALS, VETERINARY USE | $346.9K | 17 | 1 | 1.9% |
| B504 | SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL | $136.9K | 14 | 3 | 0.7% |
| B529 | SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA | $53.4K | 5 | 1 | 0.3% |
| 3590 | MISCELLANEOUS SERVICE AND TRADE EQUIPMENT | $39.9K | 2 | 1 | 0.2% |
| 6632 | ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $39.5K | 1 | 1 | 0.2% |
| 6650 | OPTICAL INSTRUMENTS, TEST EQUIPMENT, COMPONENTS AND ACCESSORIES | $23.0K | 1 | 1 | 0.1% |
08 / Competition Pattern
How was GENSCRIPT USA INC’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for GENSCRIPT USA INC?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75D30124P19829 | Sep 30, 2025 | -$50.0K | CENTERS FOR DISEASE CONTROL AND PREVENTION CDC OFFICE OF ACQUISITION SERVICES | 541714 | 6640 |
10 / Interpreting the Profile
How should you evaluate GENSCRIPT USA INC as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.